NF2 and osteosarcoma: In osteosarcoma, the transcription factor SRY-Box Transcription Factor 2 (Sox2) was shown to counteract the Hippo pathway and to restrain its two activating components, WWC1 and neurofibromin 2 (NF2, merlin in Drosophila) [36].